Regression of oral proliferative leukoplakia following initiation of ibrutinib therapy in two allogeneic hematopoietic stem cell transplant recipients
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Fantozzi, Paolo J.
Antin, Joseph H.
Text and Data Mining valid from 2020-04-09
Version of Record valid from 2020-04-09
17 February 2020
20 March 2020
25 March 2020
9 April 2020
Compliance with ethical standards
The authors declare that they have no conflict of interest.